University of South Florida, Tampa, Florida (Ms Duff); and CSL Behring LLC, King of Prussia, Pennsylvania (Mss Riley, Zampelli, and Murphy).
Carla Duff, MSN, CPNP, CCRP, is a pediatric nurse practitioner in the Division of Pediatric Allergy and Immunology at the University of South Florida/All Children's Hospital in St. Petersburg, Florida. She has many years of experience with clinical immunology and managing immunoglobulin replacement therapy for primary immunodeficient patients.
Patty Riley, BAN, RN, CRNI®, is a medical science liaison in immunology for CSL Behring. She has three decades of clinical experience in adult critical care, neurology, and immunology.
Annette Zampelli, MSN, CRNP, is a medical science liaison with CSL Behring with expertise in immunoglobulin therapies for over 20 years in the disease state areas of immunology, hematology-oncology, neurology, and transplant.
Elyse Murphy, BSN, RN, is a medical science liaison with CSL Behring with expertise in immunoglobulin therapies for over 30 years in the disease state areas of immunology, hematology-oncology, neurology, and transplant.
Corresponding Author: Carla Duff, University of South Florida, 601 5th St South, Box 7890, St. Petersburg, FL 33701 ([email protected]).
Funding Source: This program was funded by CSL Behring. CSL Behring was involved in the program design, analysis, and interpretation of data and provided funding for medical writing assistance. The authors were involved in the program design, analysis, and interpretation of data; critically revised the manuscript; and made the final decision to submit this paper for publication.
Conflict of Interest/Disclosure Information: Carla Duff serves on the nurse advisory committee for the Immune Deficiency Foundation and is a nurse consultant for CSL Behring. Elyse Murphy, Patty Riley, and Annette Zampelli are employees of CSL Behring.
